DNLI R&D Expenses
Denali Therapeutics Inc · R&D Expenses
DNLI R&D Expenses
Latest reported$400.72Mperiod ending
DNLI R&D Expenses ($11.57M → $400.72M)
Annual R&D Expenses
High-resolution chart · PNG
DNLI r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 418,778,000 | |
| 396,440,000 | |
| 423,876,000 | |
| 358,732,000 | |
| 265,353,000 | |
| 212,615,000 | |
| 193,382,000 | |
| 143,183,000 | |
| 74,460,000 | |
| 75,702,000 | |
| 11,571,000 |